Accenture (NYSE:ACN) holds firm after selloff as cyber deal at 20x tests reset
Accenture plc climbed 2.51% to $128.98 on Friday. The move outpaced the broader market, but the stock stayed deep in a hole—still 58.09% under…
All coverage
Accenture plc climbed 2.51% to $128.98 on Friday. The move outpaced the broader market, but the stock stayed deep in a hole—still 58.09% under…
Enterprise Products Partners L.P. finished Friday at $36.57, off 27 cents for the day. U.S. markets are closed Saturday. The units were volatile this…
Europe’s all-time June heat is putting cooling-system demand and grid resilience to the test. The World Meteorological Organization said the heatwave smashed late-June records…
IPO activity slows this week as U.S. equity desks face a slim calendar. Just five deals are lined up. Software buyer Bending Spoons is…
Keurig Dr Pepper Inc. rose for a third day on Friday and closed at $33.40. The headline gain was 3.44% because the tape used…
TeraWulf Inc. shares dropped Friday. Volume ran at more than twice the 65-day average. Investors sold down one of the year’s top AI-power plays,…
U.S. stocks traded during a standard session Friday, landing between the Juneteenth break on June 19 and the July 3 Independence Day holiday. The…
Freshworks Inc. was up over 5% in Friday afternoon trading. By 3:01 p.m. EDT, volume had spiked, with 30.64 million shares traded, hitting about…
AT&T Inc. ticked up Friday while the broader market slipped, but shares are still showing investors want to see cash after years of promises.…
Grab Holdings Limited moved higher on Friday in regular Nasdaq trading, rebounding from its June low as growth stocks elsewhere traded weaker.
Clearwater Analytics Holdings, Inc. is sticking near its $24.55 a share cash buyout price. The stock stopped trading as the merger closed, so the…
Strategy Inc. fell in early Friday trade, but the sharper signal for equity holders came from the company’s preferred stock, not the common shares.
Can-Fite BioPharma Ltd. rallied in premarket trading Friday after reporting a Japanese patent allowance for Namodenoson targeting obesity. The move was strong but volume…
MaaT Pharma plans to ask for a re-examination of Xervyteg after European regulators rejected the drug. The French biotech’s lead asset will face another…
Microsoft Corporation is set to trade at Friday’s U.S. open showing both growth and value traits. It’s a mechanical setup—index funds may buy or…
Intel Corporation dropped over 3% before the bell Friday as chip stocks slipped. A Micron Technology rally had faded. Nasdaq futures were off 1.16%…